Last updated on February 2018

Interferon for the Intervention of Molecular Relapse in t (8; 21) AML After Allo-HSCT


Brief description of study

molecular relapse in t (8; 21) acute myeloid leukemia (AML) after allogeneic stem cell transplantation (allo-SCT) is still a problem even after donor lymphocyte infusion.

Interferon seemed to augment graft-versus-leukemia (GVL) effect in this part of patients.

the study is to evaluate the safety and efficacy of interferon for the intervention of molecular relapse in t (8; 21) acute myeloid leukemia (AML) after allogeneic stem cell transplantation (allo-SCT)

Clinical Study Identifier: NCT02027064

Find a site near you

Start Over